Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia

ClinicalTrials.gov ID: NCT00487994

Public ClinicalTrials.gov record NCT00487994. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:02 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Randomized, Parallel Group Study to Evaluate the Safety, Tolerability and Efficacy of Lapaquistat Acetate Alone or Coadministered With Atorvastatin in Subjects With Primary Dyslipidemia

Study identification

NCT ID
NCT00487994
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
2,130 participants

Conditions and interventions

Conditions

Interventions

  • Lapaquistat acetate Drug
  • Lapaquistat acetate and atorvastatin Drug
  • Atorvastatin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2004
Primary completion
Apr 30, 2007
Completion
Apr 30, 2007
Last update posted
May 23, 2012

2004 – 2007

United States locations

U.S. sites
61
U.S. states
29
U.S. cities
61
Facility City State ZIP Site status
Not listed Birmingham Alabama
Not listed Mobile Alabama
Not listed Northport Alabama
Not listed Chandler Arizona
Not listed Phoenix Arizona
Not listed Sierra Vista Arizona
Not listed Jonesboro Arkansas
Not listed Little Rock Arkansas
Not listed Anaheim California
Not listed Rancho Cucamonga California
Not listed Santa Rosa California
Not listed Golden Colorado
Not listed Coral Gables Florida
Not listed Fort Myers Florida
Not listed Jacksonville Florida
Not listed Sarasota Florida
Not listed West Palm Beach Florida
Not listed Dunwoody Georgia
Not listed Boise Idaho
Not listed Idaho Falls Idaho
Not listed Arlington Heights Illinois
Not listed Chicago Illinois
Not listed Elk Grove Village Illinois
Not listed Evansville Indiana
Not listed Indianapolis Indiana
Not listed Waterloo Iowa
Not listed Kansas City Kansas
Not listed Overland Park Kansas
Not listed Louisville Kentucky
Not listed New Orleans Louisiana
Not listed Flint Michigan
Not listed Edina Minnesota
Not listed St Louis Missouri
Not listed Omaha Nebraska
Not listed Ship Bottom New Jersey
Not listed Rochester New York
Not listed Syracuse New York
Not listed Charlotte North Carolina
Not listed Statesville North Carolina
Not listed Wilmington North Carolina
Not listed Winston-Salem North Carolina
Not listed Cincinnati Ohio
Not listed Tulsa Oklahoma
Not listed Philadelphia Pennsylvania
Not listed Tipton Pennsylvania
Not listed Anderson South Carolina
Not listed Mt. Pleasant South Carolina
Not listed Simpsonville South Carolina
Not listed Cordova Tennessee
Not listed Morristown Tennessee
Not listed Corpus Christi Texas
Not listed Dallas Texas
Not listed Fort Worth Texas
Not listed Houston Texas
Not listed Plano Texas
Not listed San Antonio Texas
Not listed Temple Texas
Not listed Texarkana Texas
Not listed Norfolk Virginia
Not listed Richmond Virginia
Not listed Lakewood Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 67 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00487994, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 23, 2012 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00487994 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →